Most men researching treatment for an enlarged prostate hit the same wall. There are now several procedures presented as minimally invasive alternatives to traditional surgery, each described in broadly similar language — quick, outpatient, less downtime, fewer side effects — and it becomes difficult to see what actually separates them. The marketing converges even where the procedures do not.
The clearest way through is to ignore the outcome language entirely and look at what each procedure physically does to the gland. Those mechanisms are genuinely different, and almost every practical difference that matters follows from them. This post lays out the four side by side on that basis.
At Seamless Medical Centers in Port Arthur, Texas, Dr. Zagum Bhatti, Board-Certified Interventional Radiologist and Founder & Chief Medical Officer of Seamless Medical Centers, performs prostate artery embolization. We do not perform the other three, and this post does not attempt to rank them — it describes what each does so that the conversation with whoever is treating you is a better-informed one.
The One Structural Difference That Matters Most
Before the individual procedures, there is a division that organises the whole field.
Three of these four are transurethral. UroLift, Rezum, and Aquablation are all delivered by passing an instrument through the urethra to reach the prostate from the inside. Prostate artery embolization is endovascular — it reaches the gland through the arteries that supply it, with access taken at the wrist or upper thigh, and no instrument passes through the urethra at all.
That distinction drives a great deal. Transurethral approaches act directly on the tissue narrowing the channel, which means they can act on it immediately. They also involve instrumenting the urethra and the bladder neck, which is the anatomy responsible for ejaculatory function. The endovascular approach does neither: it cannot act immediately, because it works by starving tissue of blood supply so that it shrinks over subsequent weeks, but it also does not instrument the structures that transurethral approaches must pass through.
It is worth noting that this division does not track how “invasive” the procedures are in any simple sense. All four are considerably less invasive than open surgery, and grouping them by that label obscures more than it reveals. What separates them is not degree of invasiveness but route and mechanism, and those are the things that determine which anatomy each one suits.
Speed of effect and proximity to the bladder neck are, in a sense, the same trade-off viewed from two directions.
UroLift: Mechanical Retraction
The UroLift system works by holding tissue out of the way rather than removing or destroying it. Small permanent implants are placed to retract the enlarged lateral lobes of the prostate away from the urethra, mechanically widening the channel.
Nothing is cut, heated, or removed. The gland remains the size it was; the obstruction is relieved by repositioning tissue rather than reducing it. Because the effect is mechanical and immediate, relief does not depend on a period of tissue change.
The implants are permanent, which is a consideration some men weigh and others do not. Suitability depends substantially on the shape of the gland — particularly on how the lobes are configured and whether a median lobe is present — which is why anatomy assessment features heavily in candidacy for it.
Rezum: Water Vapour Thermal Therapy
Rezum uses steam. Sterile water vapour is injected into the prostate tissue, and the thermal energy released causes targeted cell death in the treated area. Over subsequent weeks the body reabsorbs the treated tissue, and the gland reduces in volume.
Unlike UroLift, this does reduce the size of the gland rather than repositioning it, so the mechanism is closer to PAE in that respect. Unlike PAE, it is delivered transurethrally and acts by thermal ablation rather than by reducing blood supply.
Because tissue is being ablated and reabsorbed, the effect develops over time rather than immediately, and a urinary catheter is typically needed for a period afterward while the treated tissue resolves.
Aquablation: Waterjet Tissue Removal
Aquablation is the most substantial of the four in terms of what it does to the gland. It uses a high-pressure waterjet, guided by real-time ultrasound imaging and delivered robotically, to remove prostate tissue.
This is genuine tissue resection — the gland is physically reduced by removing part of it. The distinguishing features relative to traditional resection are the use of a waterjet rather than heat, and image-guided robotic control of where tissue is removed.
Because it is a resective procedure, it is generally performed under anesthesia in an operating room rather than as an office-based or outpatient interventional procedure, and it involves the bleeding considerations that accompany tissue removal. It also acts immediately in the sense that the obstruction is physically removed.
PAE: Reducing the Blood Supply
Prostate artery embolization works from inside the blood vessels. A catheter is advanced through an artery, usually accessed at the wrist or upper thigh, to the vessels supplying the prostate. Particles are then delivered to reduce blood flow to the gland, which causes it to shrink gradually over subsequent weeks and months, easing pressure on the urethra.
No instrument enters the urethra, no tissue is cut or heated, and the bladder neck is not instrumented. It is performed under local anesthesia with conscious sedation rather than general anesthesia, on an outpatient basis with same-day discharge.
The trade-off is pace. Improvement is not immediate; it develops as the gland reduces, often becoming noticeable within the first several weeks with maximum benefit over roughly one to three months. Our post on PAE and sexual function covers the anatomical reasoning behind the differing side-effect profiles in more depth, and our PAE safety profile covers what the procedure’s own considerations are.
Where the Practical Differences Lie
Setting the four beside each other, several dimensions separate them, and it is worth being explicit that these follow from mechanism rather than from any claim about which works better.
Anesthesia and setting differ. PAE is performed with conscious sedation on an outpatient basis. Aquablation, as a resective procedure, generally involves anesthesia in an operating room. The transurethral energy-based approaches sit between depending on setting and patient factors.
Are You a Candidate for PAD Treatment?
If you answer "yes" to any of these questions, you may be a candidate for this treatment.
Call Now — (409) 213-9575Question 1 of 4
Have you been diagnosed with Peripheral Artery Disease (PAD) by a doctor?
Prefer to talk? Call (409) 213-9575
Your information is protected under HIPAA. We will never share your data.
Speed of effect differs. The procedures that physically remove or retract tissue act on the obstruction at the time of the procedure. Those that work by reducing or ablating tissue for later reabsorption act over weeks.
Gland size interacts differently with each. Approaches that work by removing or repositioning tissue face a scaling problem as volume increases — more tissue to address, and in some cases stated upper size limits. PAE does not scale that way, because the procedural task is vessel navigation rather than tissue removal, which is why it is often discussed specifically for larger glands. Our post on PAE for a very large prostate covers that in detail.
Gland shape interacts differently too. Configuration of the lobes, and whether a median lobe is present, bears meaningfully on suitability for some transurethral approaches.
And candidacy is established differently. PAE candidacy turns substantially on arterial anatomy — whether the vessels supplying the prostate can be safely navigated — which is a question the other three do not raise at all, and which is assessed by imaging in advance. Our post on who is and is not a candidate for PAE covers what can rule it out.
What the Current Guidance Says About PAE
For PAE specifically, two developments are worth noting. The American Urological Association’s 2026 guideline recommends PAE as a Conditional Recommendation with Grade B evidence for prostates of 50 mL or greater, an upgrade from Grade C in the prior amendment. The Society of Interventional Radiology published updated practice guidance for PAE in June 2026 in the Journal of Vascular and Interventional Radiology, replacing its 2019 multisociety consensus position statement and emphasising a team-based approach to the care of men with BPH.
We are not in a position to characterise the evidence base for procedures we do not perform, and we would treat any single practice’s comparative claims about a competitor’s device with caution — including our own. The manufacturers and the treating physicians for those procedures are the appropriate sources.
For the comparison against traditional resective surgery, our post on PAE and TURP covers that separately.
How to Use This Comparison
The useful conclusion is not that one of these is best. It is that they differ on mechanism, and that the mechanism differences map onto questions you can actually answer about yourself: how large your gland is, what shape it is, how much anesthesia risk your medical history carries, how much you weigh immediate relief against avoiding urethral instrumentation, and what your priorities are regarding ejaculatory function.
A specialist assessing you for any one of these is assessing anatomy first. What no article can tell you is which of these your particular anatomy suits, because that is established by imaging and examination rather than by reading.
Is PAE Right for You?
If urinary symptoms from an enlarged prostate are affecting your sleep and your daily routine, and you are weighing the minimally invasive options against each other, PAE may be an appropriate option worth discussing. Contact Seamless Medical Centers to arrange a consultation with Dr. Zagum Bhatti, or see the full range of procedures offered at our practice.
Phone: 409-213-9575
Address: 3300 Jimmy Johnson Blvd, Suite #130, Port Arthur, Texas 77642
Frequently Asked Questions About Comparing BPH Procedures
What is the main difference between PAE and UroLift, Rezum, or Aquablation?
Route and mechanism. UroLift, Rezum, and Aquablation are delivered through the urethra and act directly on prostate tissue — retracting it, ablating it with steam, or removing it with a waterjet. PAE is delivered through the arteries and works by reducing the gland’s blood supply so it shrinks over weeks. No instrument passes through the urethra during PAE.
Which procedure works fastest?
Approaches that physically remove or retract tissue act on the obstruction at the time of the procedure. PAE and steam-based ablation work over subsequent weeks as tissue reduces or is reabsorbed. Speed of effect is a mechanism difference, not a measure of overall effectiveness.
Does prostate size affect which procedure is suitable?
Yes. Procedures that remove or reposition tissue face a scaling problem as volume increases, and some carry stated upper size limits. PAE does not scale the same way, because the procedural task is vessel navigation rather than tissue removal.
Which procedure has the fewest sexual side effects?
We are not in a position to make comparative claims about devices we do not perform. What can be said on mechanism is that PAE does not instrument the bladder neck, which is the anatomy responsible for ejaculatory function. Discuss the specific risk profile of any procedure with the physician who performs it.
Does Seamless Medical Centers offer UroLift, Rezum, or Aquablation?
No. We perform prostate artery embolization. Part of the consultation is an honest assessment of whether PAE fits your situation, including when a different approach — one we do not perform — is the more appropriate option.
What does the AUA guideline say about PAE?
The 2026 AUA guideline recommends PAE as a Conditional Recommendation with Grade B evidence for prostates of 50 mL or greater, upgraded from Grade C in the prior amendment.
When would PAE not be appropriate?
When symptoms are not caused by obstruction, when the prostatic arterial anatomy cannot be safely navigated, or when kidney function, contrast allergy, an uncorrectable bleeding disorder, or active infection makes the procedure inadvisable. In those situations another approach may be the better fit.
Medical Disclaimer
Individual results may vary. This information is for educational purposes only and should not replace professional medical advice. Treatment decisions should be made in consultation with qualified healthcare providers. UroLift, Rezum, and Aquablation are registered trademarks of their respective manufacturers; this article describes their mechanisms for comparison and is not affiliated with or endorsed by them.
Published by Seamless Medical Centers | Clinical information reflects the expertise of Dr. Zagum Bhatti, MD, Board-Certified Interventional Radiologist, Founder of Seamless Medical Centers.
Why Choose Seamless Medical Centers?
- Minimally Invasive: Most procedures require only a small incision and are performed as outpatient services.
- Expert Care: Board-certified interventional radiologists with extensive training and experience.
- Faster Recovery: Less downtime compared to traditional surgery, getting you back to your life sooner.
- Advanced Technology: State-of-the-art imaging and treatment equipment for precise, effective care.
- Patient-Centered: Personalized treatment plans tailored to your unique needs and goals.
Why Choose Seamless Medical Centers?
- Minimally Invasive: Most procedures require only a small incision and are performed as outpatient services.
- Expert Care: Board-certified interventional radiologists with extensive training and experience.
- Faster Recovery: Less downtime compared to traditional surgery, getting you back to your life sooner.
- Advanced Technology: State-of-the-art imaging and treatment equipment for precise, effective care.
- Patient-Centered: Personalized treatment plans tailored to your unique needs and goals.
